JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 4 591-603
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delbeke, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delbeke, D.

Oncological Applications of FDG PET Imaging: Brain Tumors, Colorectal Cancer Lymphoma and Melanoma*

Dominique Delbeke

Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee

Correspondence: For correspondence or reprints contact: Dominique Delbeke, MD, PhD, Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, 2lst Avenue South and Garland, Nashville, TN 37232-2675.

ABSTRACT

This article will focus primarily on body oncology diagnosis, staging and therapy monitoring using fluorodeoxyglucose (FDG) PET imaging. Common pitfalls and artifacts in body FDG imaging will be covered. Examples of diagnosis, staging and therapy monitoring of brain tumor, colorectal cancer, lymphoma and melanoma will be given. Importance of correlation with anatomic imaging and practical use of FDG imaging in patient management will be stressed.

Key Words: emission CT • fluorine • glucose • metabolism • neoplasms

FOOTNOTES

NOTE: FOR CE CREDIT, YOU CAN ACCESS THIS ARTICLE ON THE SNM WEBSITE (http://www.snm.org) UNTIL OCTOBER 1999.




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
J. Y. Kwak, E.-K. Kim, M. Yun, A. Cho, M. J. Kim, E. J. Son, and K. K. Oh
Thyroid Incidentalomas Identified by 18F-FDG PET: Sonographic Correlation
Am. J. Roentgenol., August 1, 2008; 191(2): 598 - 603.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Masciari, A. D. Van den Abbeele, L. R. Diller, I. Rastarhuyeva, J. Yap, K. Schneider, L. Digianni, F. P. Li, J. F. Fraumeni Jr, S. Syngal, et al.
F18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome
JAMA, March 19, 2008; 299(11): 1315 - 1319.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, and P. T. Scardino
Imaging Prostate Cancer: A Multidisciplinary Perspective
Radiology, April 1, 2007; 243(1): 28 - 53.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H.-E. Wang, H.-M. Yu, R.-S. Liu, M. Lin, J. G. Gelovani, J.-J. Hwang, H.-J. Wei, and W.-P. Deng
Molecular Imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer
J. Nucl. Med., July 1, 2006; 47(7): 1161 - 1171.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Tatsumi, C. Cohade, Y. Nakamoto, E. K. Fishman, and R. L. Wahl
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
Radiology, December 1, 2005; 237(3): 1038 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Gutman, J.-L. Alberini, M. Wartski, D. Vilain, E. Le Stanc, F. Sarandi, C. Corone, C. Tainturier, and A. P. Pecking
Incidental Colonic Focal Lesions Detected by FDG PET/CT
Am. J. Roentgenol., August 1, 2005; 185(2): 495 - 500.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. V. Sahani, S. P. Kalva, A. J. Fischman, R. Kadavigere, M. Blake, P. F. Hahn, and S. Saini
Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir Trisodium-Enhanced Liver MRI and Whole-Body FDG PET
Am. J. Roentgenol., July 1, 2005; 185(1): 239 - 246.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. C.A. van Kouwen, F. M. Nagengast, J. B.M.J. Jansen, W. J.G. Oyen, and J. P.H. Drenth
2-(18F)-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Detects Clinical Relevant Adenomas of the Colon: A Prospective Study
J. Clin. Oncol., June 1, 2005; 23(16): 3713 - 3717.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Ishimori, P. V. Patel, and R. L. Wahl
Detection of Unexpected Additional Primary Malignancies with PET/CT
J. Nucl. Med., May 1, 2005; 46(5): 752 - 757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. Pandit-Taskar, H. Schoder, M. Gonen, S. M. Larson, and H. W. D. Yeung
Clinical Significance of Unexplained Abnormal Focal FDG Uptake in the Abdomen During Whole-Body PET
Am. J. Roentgenol., October 1, 2004; 183(4): 1143 - 1147.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Tatsumi, C. Cohade, Y. Nakamoto, and R. L. Wahl
Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis
Radiology, December 1, 2003; 229(3): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Schiepers
PET/CT in Colorectal Cancer
J. Nucl. Med., November 1, 2003; 44(11): 1804 - 1805.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
U. Guller, E. Nitzsche, H. Moch, and M. Zuber
Is Positron Emission Tomography an Accurate Non-invasive Alternative to Sentinel Lymph Node Biopsy in Breast Cancer Patients?
J Natl Cancer Inst, July 16, 2003; 95(14): 1040 - 1043.
[Full Text] [PDF]


Home page
NeurologyHome page
G. Antoch, T. Egelhof, S. Korfee, M. Frings, M. Forsting, and A. Bockisch
Recurrent schwannoma: Diagnosis with PET/CT
Neurology, October 22, 2002; 59(8): 1240 - 1240.
[Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S. Himeno, S. Yasuda, H. Shimada, T. Tajima, and H. Makuuchi
Evaluation of Esophageal Cancer by Positron Emission Tomography
Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
T. Belhocine, G. Pierard, M. de Labrassinne, T. Lahaye, and P. Rigo
Staging of Regional Nodes in AJCC Stage I and II Melanoma: 18FDG PET Imaging versus Sentinel Node Detection
Oncologist, August 1, 2002; 7(4): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Ishimori, T. Saga, M. Mamede, H. Kobayashi, T. Higashi, Y. Nakamoto, N. Sato, and J. Konishi
Increased 18F-FDG Uptake in a Model of Inflammation: Concanavalin A-Mediated Lymphocyte Activation
J. Nucl. Med., May 1, 2002; 43(5): 658 - 663.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
B. Rydzewski, F. Dehdashti, B. A. Gordon, S. A. Teefey, S. M. Strasberg, and B. A. Siegel
Usefulness of Intraoperative Sonography for Revealing Hepatic Metastases from Colorectal Cancer in Patients Selected for Surgery After Undergoing FDG PET
Am. J. Roentgenol., February 1, 2002; 178(2): 353 - 358.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. R. DeGrado, S. W. Baldwin, S. Wang, M. D. Orr, R. P. Liao, H. S. Friedman, R. Reiman, D. T. Price, and R. E. Coleman
Synthesis and Evaluation of 18F-Labeled Choline Analogs as Oncologic PET Tracers
J. Nucl. Med., December 1, 2001; 42(12): 1805 - 1814.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
S F Barrington
Whole body applications of positron emission tomography in oncology
Imaging, September 1, 2001; 13(3): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Takeda, H. Tamano, S. Enomoto, and N. Oku
Zinc-65 Imaging of Rat Brain Tumors
Cancer Res., July 1, 2001; 61(13): 5065 - 5069.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ziegler, M. v. Kienlin, M. Decorps, and C. Remy
High Glycolytic Activity in Rat Glioma Demonstrated in Vivo by Correlation Peak 1H Magnetic Resonance Imaging
Cancer Res., July 1, 2001; 61(14): 5595 - 5600.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Rahmouni, M. Divine, E. Lepage, N. Jazaerli, K. Belhadj, P. Gaulard, M. Golli, F. Reyes, and N. Vasile
Mediastinal Lymphoma: Quantitative Changes in Gadolinium Enhancement at MR Imaging after Treatment
Radiology, June 1, 2001; 219(3): 621 - 628.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Tatsumi, H. Kitayama, H. Sugahara, N. Tokita, H. Nakamura, Y. Kanakura, and T. Nishimura
Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
J. Nucl. Med., April 1, 2001; 42(4): 601 - 608.
[Abstract] [Full Text]


Home page
RadiologyHome page
D. Delbeke, W. H. Martin, J. A. Patton, and M. P. Sandler
Value of Iterative Reconstruction,AttenuationCorrection,and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation Maps
Radiology, January 1, 2001; 218(1): 163 - 171.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. R. DeGrado, R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price
Synthesis and Evaluation of 18F-labeled Choline as an Oncologic Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer
Cancer Res., January 1, 2000; 61(1): 110 - 117.
[Abstract] [Full Text]


Home page
RadiologyHome page
M. Gonen, K. S. Panageas, and S. M. Larson
Statistical Issues in Analysis of Diagnostic Imaging Experiments with Multiple Observations per Patient
Radiology, December 1, 2001; 221(3): 763 - 767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.